↑Liu, Y; Takeshita A, Misiti S, Chin W W, Yen P M (Oct. de 1998). «Lack of coactivator interaction can be a mechanism for dominant negative activity by mutant thyroid hormone receptors». Endocrinology (UNITED STATES) 139 (10): 4197-204. ISSN0013-7227. PMID9751500.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Jeyakumar, M; Tanen M R, Bagchi M K (Jun. de 1997). «Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor». Mol. Endocrinol. (UNITED STATES) 11 (6): 755-67. ISSN0888-8809. PMID9171239.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Tzortzakaki, Eleni; Spilianakis Charalambos, Zika Eleni, Kretsovali Androniki, Papamatheakis Joseph (Dec. de 2003). «Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways». Mol. Endocrinol. (United States) 17 (12): 2509-18. ISSN0888-8809. PMID12933903. doi:10.1210/me.2002-0439.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Zhang, C; Baudino T A, Dowd D R, Tokumaru H, Wang W, MacDonald P N (Nov. de 2001). «Ternary complexes and cooperative interplay between NCoA-62/Ski-interacting protein and steroid receptor coactivators in vitamin D receptor-mediated transcription». J. Biol. Chem. (United States) 276 (44): 40614-20. ISSN0021-9258. PMID11514567. doi:10.1074/jbc.M106263200.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Masiello, David; Chen Shao-Yong, Xu Youyuan, Verhoeven Manon C, Choi Eunis, Hollenberg Anthony N, Balk Steven P (Oct. de 2004). «Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells». Mol. Endocrinol. (United States) 18 (10): 2388-401. ISSN0888-8809. PMID15256534. doi:10.1210/me.2003-0436.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Zilliacus, J; Holter E, Wakui H, Tazawa H, Treuter E, Gustafsson J A (Apr. de 2001). «Regulation of glucocorticoid receptor activity by 14--3-3-dependent intracellular relocalization of the corepressor RIP140». Mol. Endocrinol. (United States) 15 (4): 501-11. ISSN0888-8809. PMID11266503.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Treuter, E; Albrektsen T, Johansson L, Leers J, Gustafsson J A (Jun. de 1998). «A regulatory role for RIP140 in nuclear receptor activation». Mol. Endocrinol. (UNITED STATES) 12 (6): 864-81. ISSN0888-8809. PMID9626662.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
123Lee, S K; Na S Y, Jung S Y, Choi J E, Jhun B H, Cheong J, Meltzer P S, Lee Y C, Lee J W (Jun. de 2000). «Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2». Mol. Endocrinol. (UNITED STATES) 14 (6): 915-25. ISSN0888-8809. PMID10847592.La referencia utiliza el parámetro obsoleto |coautores= (ayuda)
↑Litterst, C M; Pfitzner E (Dec. de 2001). «Transcriptional activation by STAT6 requires the direct interaction with NCoA-1». J. Biol. Chem. (United States) 276 (49): 45713-21. ISSN0021-9258. PMID11574547. doi:10.1074/jbc.M108132200.